Gevo

OverviewSuggest Edit

Gevo is a renewable chemicals and advanced biofuels company. The Company has developed bio-based alternatives to petroleum-based products using a combination of synthetic biology and chemistry. Gevo produces isobutanol, a versatile platform chemical for the liquid fuels and petrochemical market. Isobutanol has broad market applications as a solvent and a gasoline blendstock that can help refiners meet their renewable fuel and clean air obligations. It can also be further processed using well-known chemical processes into jet fuel and feedstocks for the production of synthetic rubber, plastics, and polyesters. Gevo's technology was designed to retrofit existing ethanol plants of all kinds.

TypePublic
Founded2005
HQEnglewood, USMap
Websitegevo.com
Employee Ratings2.6More
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)57(+10%)
Revenue (FY, 2019)$24.5 M(-25%)
Share Price (Oct 2020)$1.2
Cybersecurity ratingBMore

Key People/Management at Gevo

Patrick R. Gruber

Patrick R. Gruber

Board Member, Chief Executive Officer
Geoffrey T. Williams

Geoffrey T. Williams

General Counsel & Secretary
Lynn Smull

Lynn Smull

Chief Financial Officer
Andrew J. Marsh

Andrew J. Marsh

Board Member, Chair of the Compensation Committee, Member of the Compensation Committee
Johannes Minho Roth

Johannes Minho Roth

Board Member, Member of the Audit Committee
Gary W. Mize

Gary W. Mize

Board Member, Chair of the Audit Committee, Member of the Compensation Committee
Show more

Gevo Office Locations

Gevo has an office in Englewood
Englewood, US (HQ)
345 Inverness Dr S
Show all (1)

Gevo Financials and Metrics

Gevo Revenue

Embed Graph
View revenue for all periods
Gevo's revenue was reported to be $24.49 m in FY, 2019
USD

Revenue (Q1, 2020)

3.8m

Gross profit (Q1, 2020)

(4.3m)

Gross profit margin (Q1, 2020), %

(112.8%)

Net income (Q1, 2020)

(9.3m)

EBIT (Q1, 2020)

(8.0m)

Market capitalization (16-Oct-2020)

92.4m

Closing stock price (16-Oct-2020)

1.2

Cash (30-Jun-2020)

6.3m
Gevo's current market capitalization is $92.4 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

64.5m24.4m8.2m28.3m30.1m27.2m27.5m32.9m24.5m

Revenue growth, %

244%7%(10%)

Cost of goods sold

60.6m32.4m14.5m35.6m38.8m37.0m38.2m41.6m36.7m

Gross profit

4.0m(8.0m)(6.3m)(7.3m)(8.6m)(9.8m)(10.6m)(8.7m)(12.2m)
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

14.5m17.5m14.9m7.0m3.5m1.9m1.1m903.0k7.7m10.1m5.9m8.9m8.0m6.3m8.1m6.9m5.6m7.5m7.7m8.2m9.4m8.6m6.4m5.1m6.1m3.8m

Cost of goods sold

13.6m16.2m15.0m8.5m2.0m2.7m4.7m4.7m8.3m11.8m9.2m9.9m10.6m9.2m10.0m9.7m9.4m9.7m9.7m10.6m10.7m10.6m9.0m8.5m9.9m8.1m

Gross profit

896.0k1.3m(138.0k)(1.5m)1.5m(837.0k)(3.6m)(3.8m)(548.0k)(1.6m)(3.3m)(974.0k)(2.6m)(2.9m)(1.9m)(2.7m)(3.8m)(2.2m)(2.0m)(2.3m)(1.3m)(2.1m)(2.6m)(3.4m)(3.8m)(4.3m)

Gross profit Margin, %

6%7%(1%)(21%)42%(45%)(320%)(418%)(7%)(16%)(57%)(11%)(33%)(46%)(23%)(39%)(68%)(29%)(26%)(28%)(14%)(24%)(40%)(66%)(62%)(113%)
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

94.2m66.7m24.6m6.4m17.0m27.9m11.6m33.7m16.3m

Accounts Receivable

2.9m698.0k1.4m2.4m1.4m1.1m1.1m526.0k1.1m

Prepaid Expenses

1.3m1.5m1.2m732.0k731.0k712.0k1.3m3.6m

Inventories

3.8m6.7m3.6m4.3m3.5m3.5m4.4m3.2m3.2m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

105.2m97.6m73.6m38.6m92.0m54.1m40.6m25.7m8.4m5.9m14.0m4.4m22.5m16.2m8.7m22.6m31.1m20.4m16.3m14.8m7.0m27.0m38.3m35.5m29.2m20.9m9.3m6.3m

Accounts Receivable

2.4m2.7m3.0m1.1m736.0k1.0m498.0k867.0k1.7m3.1m2.0m2.1m2.3m1.1m869.0k1.7m1.1m1.2m1.4m1.2m1.3m1.4m637.0k1.1m166.0k378.0k152.0k746.0k

Prepaid Expenses

922.0k1.3m1.6m1.2m1.2m1.7m1.5m1.3m1.1m935.0k861.0k553.0k571.0k618.0k1.0m884.0k844.0k860.0k964.0k828.0k633.0k15.3m949.0k1.9m1.5m1.6m3.8m3.8m

Inventories

6.4m5.0m5.5m2.9m3.8m4.4m3.4m4.2m3.7m4.2m4.0m4.5m2.9m2.7m3.0m2.9m3.2m4.2m4.3m4.3m4.4m3.8m3.3m3.2m3.3m3.0m2.7m2.5m
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(48.2m)(60.7m)(66.8m)(41.1m)(36.2m)(37.2m)(24.6m)(28.0m)(28.7m)

Depreciation and Amortization

4.6m3.3m3.4m4.9m6.6m6.7m6.6m6.5m6.7m

Inventories

(49.0k)(2.8m)2.1m(711.0k)805.0k29.0k(904.0k)1.2m(35.0k)

Accounts Payable

2.6m(3.3m)2.6m(1.6m)(2.8m)(697.0k)(1.7m)(313.0k)1.3m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(21.7m)(34.1m)(19.3m)(35.5m)(62.5m)(18.4m)(33.6m)(49.5m)(12.0m)(29.1m)(30.1m)(7.3m)(21.7m)(28.2m)(3.6m)(25.1m)(34.9m)(5.9m)(16.1m)(20.2m)(2.5m)(14.0m)(20.9m)(6.1m)(13.2m)(21.8m)(9.3m)(15.3m)

Depreciation and Amortization

2.2m3.4m788.0k1.6m2.5m849.0k1.7m2.6m826.0k1.6m3.2m1.7m3.3m4.9m1.6m3.3m5.0m1.7m3.3m5.0m1.6m3.3m4.9m1.6m3.2m4.8m1.6m3.3m

Inventories

(2.6m)(1.2m)(1.6m)959.0k16.0k2.2m3.2m1.8m(142.0k)(661.0k)(446.0k)(207.0k)1.4m1.6m500.0k602.0k284.0k(720.0k)(838.0k)(873.0k)7.0k516.0k1.1m(21.0k)(163.0k)204.0k520.0k721.0k

Accounts Payable

(441.0k)1.8m(834.0k)368.0k2.1m1.3m2.6m6.0m(496.0k)(2.2m)(2.9m)(1.0m)(2.1m)(2.0m)(1.3m)(1.9m)(2.1m)(1.2m)(1.3m)(766.0k)(531.0k)(829.0k)104.0k(1.1m)(38.0k)255.0k(1.1m)(1.5m)
show all
USDQ2, 2011

Financial Leverage

1.2 x
Show all financial metrics

Gevo Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

Learn more about about our premium products
SecurityScorecard logo

Gevo Online and Social Media Presence

Gevo's Trends

Embed Graph

Gevo News and Updates

October 08, 2020

Thinking about buying stock in Gevo Inc, Intec Pharma, Advanced Micro Devices, Norwegian Cruise Line, or Sorrento Therapeutics?

NEW YORK, Oct. 8, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, NTEC, AMD, NCLH, and SRNE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
September 04, 2020

Thinking about buying stock in Gevo Inc, Kitov Pharma, Plug Power, American Airlines, or Vuzix Corp?

NEW YORK, Sept. 4, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, KTOV, PLUG, AAL, and VUZI. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
August 24, 2020

Thinking about buying stock in Gevo Inc, Foot Locker, Harpoon Therapeutics, Eyepoint Pharmaceuticals, or GameStop Corp.?

NEW YORK, Aug. 24, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, FL, HARP, EYPT, and GME. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
August 21, 2020

Thinking about buying stock in Gevo Inc, Mobileiron Inc, Cytokinetics Inc, Sorrento Therapeutics, or Advanced Micro Devices?

NEW YORK, Aug. 21, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, MOBL, CYTK, SRNE, and AMD. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
August 21, 2020

Gevo, Inc. Announces $50 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

ENGLEWOOD, Colo., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Gevo, Inc. (“Gevo”) (Nasdaq: GEVO), today announced that it has entered into definitive agreements with institutional and accredited investors for the sale of an aggregate of 38,461,545 shares of common stock (or common stock equivalents) at a pu…
July 07, 2020

Thinking about buying stock in Seanergy Maritime Holdings, Kitov Pharma, Gevo Inc, Vivint Solar, or Hepion Pharmaceuticals?

NEW YORK, July 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SHIP, KTOV, GEVO, VSLR, and HEPA. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
Show more

Gevo Blogs

June 18, 2020

Gevo Values Certification from International Third-Party Groups that Track Sustainability

Gevo, Inc., understands that sustainability is more than just a marketing tool or selling point for its bio-based, renewable fuels. It’s also a metric that can be scientifically measured and documented. The sustainability of any product, along with ethical and credible sourcing, will be a guide for …
May 13, 2020

Gevo, Inc. Brand Guidelines

Here are the Brand Guidelines for Gevo, Inc. The post Gevo, Inc. Brand Guidelines appeared first on Gevo.
May 04, 2020

Advanced Agriculture: Our Farmers Use Techniques that Boost Yield and Improve the Soil

The creation of renewable next-generation fuel begins in America’s Heartland, where No. 2 yellow dent corn is raised in vast quantities by farmers who have been stewards of the land for generations. These farmers know their plots, and they understand how to get more corn out of each acre. Their land…
May 01, 2020

The Ethics and Morals of Renewable Fuel

Sustainability is a principle that makes sense on every level. For Gevo, it means adhering to the highest standards of environmental and economic responsibility, using the latest synthetic biology and industrial chemistry to achieve something that’s better for us, and for the whole world. The post T…
Show more

 Gevo Frequently Asked Questions

  • When was Gevo founded?

    Gevo was founded in 2005.

  • Who are Gevo key executives?

    Gevo's key executives are Patrick R. Gruber, Geoffrey T. Williams and Lynn Smull.

  • How many employees does Gevo have?

    Gevo has 57 employees.

  • What is Gevo revenue?

    Latest Gevo annual revenue is $24.5 m.

  • What is Gevo revenue per employee?

    Latest Gevo revenue per employee is $429.6 k.

  • Who are Gevo competitors?

    Competitors of Gevo include Borregaard ASA, ZeaChem and Linka Energy.

  • Where is Gevo headquarters?

    Gevo headquarters is located at 345 Inverness Dr S, Englewood.

  • Where are Gevo offices?

    Gevo has an office in Englewood.

  • How many offices does Gevo have?

    Gevo has 1 office.